Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03066843
NA

Photodynamic Therapy Incubation Times for Actinic Keratosis

Sponsor: Northwestern University

View on ClinicalTrials.gov

Summary

This is a randomized clinical trial evaluating blue light 5-aminolevulinic acid (ALA) photodynamic therapy with different incubation times for the treatment of actinic keratosis. Subjects who are interested in participating, currently living in the Chicago metropolitan area, and meet inclusion and exclusion criteria will be enrolled in the study. Subjects will be randomized to either 1) zero time ALA incubation or 2) 1 hour ALA incubation. Demographic and health data will be collected prior to treatment initiation. Three visits will be conducted: screening, treatment, and follow up visit at 8 weeks. This study is a pilot study designed to determine feasibility of this procedure.

Official title: A Randomized Controlled Trial Evaluating 5-aminolevulinic Acid Photodynamic Therapy With Different Incubation Times for the Treatment of Actinic Keratosis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2017-03-01

Completion Date

2025-12

Last Updated

2025-01-31

Healthy Volunteers

Yes

Interventions

DRUG

ALA (5-aminolevulinic acid)

ALA (5-aminolevulinic acid) will be applied to subjects' skin for either zero time incubation or one hour incubation

DEVICE

Blue light therapy

Subjects will be exposed to blue light

Locations (1)

Northwestern University Feinberg School of Medicine, Department of Dermatology

Chicago, Illinois, United States